查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1704653

2025年全球体外肺部模型市场报告

In-Vitro Lung Model Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年体外肺模型市场规模将呈指数级增长。到 2029 年，这一数字将成长至 11.6 亿美元，复合年增长率为 21.0%。预测期内的增长可归因于药物开发的需求、临床前试验的增加、对呼吸毒理学认识的不断提高、对再生医学的关注、对环境问题的日益关注以及老年人口的增长。预测期内的关键趋势包括对药物测试的需求不断增加、3D 列印技术的进步、器官晶片技术的进步、人工智慧和机器学习的融合、感测器和监测设备的融合、非药物应用的扩大以及针对特异性疾病的模型的开发。

预计临床试验的激增将在未来几年推动体外肺模型市场的成长。临床试验是评估新医疗方法对人类的有效性的研究。临床研究的成长是由对先进医疗治疗的需求不断增长、医疗保健需求不断增长以及对复杂健康挑战的创新解决方案的寻求所推动的。试管内，它提供了一个受控的环境来研究物质如何影响肺组织，并有助于测试药物、评估毒性、模拟疾病和了解疾病机制。例如，根据美国临床试验註册中心ClinicalTrials.gov的数据，截至2024年1月，全球整体註册的临床试验数量为477,230项，高于2022年的437,508项。因此，越来越多的临床试验正在刺激体外肺模型市场的发展。

体外肺部模型市场的关键参与者正在开发 3D 呼吸组织模型，以增加生理相关性和模型复杂性。这些模型是透过在专门的环境中培养选定的呼吸细胞而创建的，从而使它们形成模拟呼吸系统功能和形态的3D结构。这为研究和药物测试提供了一个更生理相关的平台。例如，2023年4月，美国生物技术公司MatTek Corporation推出了EpiNasal，这是一种由原代人类鼻上皮细胞製成的创新3D呼吸组织模型。 EpiNasal 再现了鼻上皮的3D结构和功能，包括产生黏液的杯状细胞、功能性紧密连接和跳动的纤毛。 EpiNasal 的推出扩展了 MatTek 的 3D 呼吸组织模型范围，为研究药物、化学物质、病原体和消费品对人体呼吸系统的影响提供了全面的系统。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球体外肺模型PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球体外肺模型市场：增长率分析
  • 全球体外肺模型市场表现：规模与成长，2019-2024
  • 全球体外肺模型市场预测：规模与成长，2024-2029 年，2034 年
  • 体外肺模型的全球总目标市场（TAM）

第六章市场区隔

  • 全球体外肺模型市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 二维（2D）模型
  • 3D（3D）模型
  • 全球体外肺模型市场的应用、效能及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 药物研发与毒理学研究
  • 生理学研究
  • 3D（3D）模型开发
  • 其他用途
  • 全球体外肺模型市场：依最终使用者、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究所
  • 製药和生物技术公司
  • 其他最终用户
  • 全球体外肺模型市场二维 (2D) 模型细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 单层细胞培养
  • 共培养
  • 全球体外肺模型市场3D（3D）模型细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 球形体
  • 类器官
  • 晶片肺模型

第七章 区域和国家分析

  • 全球离体肺模型市场：依地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球离体肺模型市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 体外肺部模型市场：竞争格局
  • 体外肺模型市场：公司简介
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Epithelix
  • The Charles Stark Draper Laboratory Inc.
  • STEMCELL Technologies
  • American Type Culture Collection（ATCC）
  • BioIVT
  • InSphero
  • Emulate Inc.
  • PhoenixBio Co. Ltd.
  • Newcells Biotech
  • CN Bio Innovations Ltd.
  • Mimetas
  • Cyfuse Biomedical KK
  • 3D Biotek LLC
  • AlveoliX AG
  • AxoSim Technologies LLC

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年体外肺模型市场：提供新机会的国家
  • 2029年体外肺模型市场：细分市场带来新机会
  • 2029年体外肺部模型市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r30515

An in vitro lung model is a scientific construct devised to replicate the cellular, structural, and functional characteristics of the human lung within a controlled laboratory setting. These models empower researchers to explore disease progression, identify biomarkers, and evaluate treatment effectiveness. They serve as invaluable instruments for advancing our comprehension of lung biology, refining therapeutic approaches, and enhancing health outcomes.

The primary classifications of in vitro lung models include two-dimensional (2D) models and three-dimensional (3D) models. A 2D model presents a simplified depiction of lung cells and tissue on a flat surface, employed in fundamental research and preliminary substance testing. They find utility across various domains such as drug discovery, toxicology assessments, physiological investigations, as well as the advancement of three-dimensional (3D) model methodologies. These models are utilized by academic research institutions, pharmaceutical and biotechnology firms, among others.

The in vitro lung model market research report is one of a series of new reports from The Business Research Company that provides in vitro lung model market statistics, including the in vitro lung model industry global market size, regional shares, competitors with in vitro lung model market share, detailed in vitro lung model market segments, market trends, and opportunities, and any further data you may need to thrive in the in vitro lung model industry. These in vitro lung model market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The in-vitro lung model market size has grown exponentially in recent years. It will grow from $0.44 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 21.3%. The growth in the historic period can be attributed to growing prevalence of respiratory diseases, increased focus on personalized medicine, growing interest in drug repurposing, emphasis on precision medicine approaches, growing awareness of environmental health risks.

The in-vitro lung model market size is expected to see exponential growth in the next few years. It will grow to $1.16 billion in 2029 at a compound annual growth rate (CAGR) of 21.0%. The growth in the forecast period can be attributed to drug development needs, rise in preclinical testing, increasing awareness of respiratory toxicology, focusing on regenerative medicine, growing environmental concerns, increasing geriatric populations. Major trends in the forecast period include increased demand for drug testing, advancements in 3D printing technology, advancements in organ-on-chip technology, integration of AI and machine learning, integration of sensors and monitoring devices, expansion of applications beyond pharmaceuticals, development of disease-specific models.

The surge in clinical studies is anticipated to drive growth in the in vitro lung model market in the future. Clinical trials are investigations that evaluate the effectiveness of new medical approaches in human subjects. This increase in clinical studies is propelled by the growing demand for advanced medical treatments, rising healthcare needs, and the search for innovative solutions to complex health challenges. In vitro lung models play a crucial role in clinical trials by providing a controlled setting to examine how substances affect lung tissue, aiding in drug testing, assessing toxicity, modeling diseases, and understanding disease mechanisms. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, as of January 2024, there were 477,230 registered clinical trials globally, up from 437,508 in 2022. Consequently, the rise in clinical studies stimulates the in vitro lung model market.

Key players in the in vitro lung model market are developing 3D respiratory tissue models to enhance the physiological relevance and complexity of their models. These models are created by culturing selected respiratory cells in a specialized environment, allowing them to form a three-dimensional structure that mimics the function and morphology of the respiratory system. This provides a more physiologically relevant platform for research and drug testing. For example, in April 2023, MatTek Corporation, a US-based biotechnology company, launched EpiNasal, an innovative 3D respiratory tissue model made from primary human nasal epithelial cells. EpiNasal replicates the three-dimensional structure and functionality of nasal epithelium, including mucus-producing goblet cells, functional tight junctions, and beating cilia. The introduction of EpiNasal expands MatTek's range of 3D respiratory tissue models, offering a comprehensive system for studying the effects of pharmaceuticals, chemicals, pathogens, and consumer products on the human respiratory system.

In July 2024, Tergus Pharma, a US-based end-to-end service provider for topical pharmaceutical products, merged with MedPharm Ltd. for an undisclosed amount. This strategic merger combines the strengths of both companies, allowing them to offer a comprehensive range of services, including commercial production and serialization, formulation development, in vitro testing, and clinical manufacturing, all within a single integrated organization. The merger enhances their capabilities in developing and manufacturing hormone-based and highly potent drugs at Tergus Pharma's GMP manufacturing facility in Durham, NC. MedPharm Ltd., based in the UK, specializes in providing in vitro models that use human tissue to simulate lung and nasal delivery systems.

Major companies operating in the in-vitro lung model market are Thermo Fisher Scientific Inc., Lonza Group AG, PerkinElmer Inc., Charles River Laboratories International Inc., Varian Medical Systems Inc., Epithelix, The Charles Stark Draper Laboratory Inc., STEMCELL Technologies, American Type Culture Collection (ATCC), BioIVT, InSphero, Emulate Inc., PhoenixBio Co. Ltd., Newcells Biotech, CN Bio Innovations Ltd., Mimetas, Cyfuse Biomedical K.K., 3D Biotek LLC, AlveoliX AG, AxoSim Technologies LLC, Elveflow, Hesperos Inc., Kugelmeiers Ag, SynVivo Inc., VITROCELL Systems GmbH

North America was the largest region in the in-vitro lung model market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro lung model market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in-vitro lung model market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro lung model market consists of revenue earned by providing services such as customization services, training and education services, medical education, healthcare training, forensic science, repair and maintenance services, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The In-vitro lung model models market also includes sales of anatomical organ models, muscle models, human skeleton models, anatomical charts, and posters. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Lung Model Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in-vitro lung model market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro lung model ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The in-vitro lung model market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Two-Dimensional (2D) Model; Three-Dimensional (3D) Model
  • 2) By Application: Drug Discovery And Toxicology Studies; Physiological Research; Three-Dimensional (3D) Model Development; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Other End-Users
  • Subsegments:
  • 1) By Two-Dimensional (2D) Model: Monolayer Cell Cultures; Co-cultures
  • 2) By Three-Dimensional (3D) Model: Spheroids; Organoids; Lung-On-A-chip Models
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Lonza Group AG; PerkinElmer Inc.; Charles River Laboratories International Inc.; Varian Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In-Vitro Lung Model Market Characteristics

3. In-Vitro Lung Model Market Trends And Strategies

4. In-Vitro Lung Model Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global In-Vitro Lung Model Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In-Vitro Lung Model PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In-Vitro Lung Model Market Growth Rate Analysis
  • 5.4. Global In-Vitro Lung Model Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In-Vitro Lung Model Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In-Vitro Lung Model Total Addressable Market (TAM)

6. In-Vitro Lung Model Market Segmentation

  • 6.1. Global In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Two-Dimensional (2D) Model
  • Three-Dimensional (3D) Model
  • 6.2. Global In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Toxicology Studies
  • Physiological Research
  • Three-Dimensional (3D) Model Development
  • Other Applications
  • 6.3. Global In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Other End-Users
  • 6.4. Global In-Vitro Lung Model Market, Sub-Segmentation Of Two-Dimensional (2D) Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monolayer Cell Cultures
  • Co-cultures
  • 6.5. Global In-Vitro Lung Model Market, Sub-Segmentation Of Three-Dimensional (3D) Model, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Spheroids
  • Organoids
  • Lung-On-A-chip Models

7. In-Vitro Lung Model Market Regional And Country Analysis

  • 7.1. Global In-Vitro Lung Model Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In-Vitro Lung Model Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In-Vitro Lung Model Market

  • 8.1. Asia-Pacific In-Vitro Lung Model Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In-Vitro Lung Model Market

  • 9.1. China In-Vitro Lung Model Market Overview
  • 9.2. China In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In-Vitro Lung Model Market

  • 10.1. India In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In-Vitro Lung Model Market

  • 11.1. Japan In-Vitro Lung Model Market Overview
  • 11.2. Japan In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In-Vitro Lung Model Market

  • 12.1. Australia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In-Vitro Lung Model Market

  • 13.1. Indonesia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In-Vitro Lung Model Market

  • 14.1. South Korea In-Vitro Lung Model Market Overview
  • 14.2. South Korea In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In-Vitro Lung Model Market

  • 15.1. Western Europe In-Vitro Lung Model Market Overview
  • 15.2. Western Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In-Vitro Lung Model Market

  • 16.1. UK In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In-Vitro Lung Model Market

  • 17.1. Germany In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In-Vitro Lung Model Market

  • 18.1. France In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In-Vitro Lung Model Market

  • 19.1. Italy In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In-Vitro Lung Model Market

  • 20.1. Spain In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In-Vitro Lung Model Market

  • 21.1. Eastern Europe In-Vitro Lung Model Market Overview
  • 21.2. Eastern Europe In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In-Vitro Lung Model Market

  • 22.1. Russia In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In-Vitro Lung Model Market

  • 23.1. North America In-Vitro Lung Model Market Overview
  • 23.2. North America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In-Vitro Lung Model Market

  • 24.1. USA In-Vitro Lung Model Market Overview
  • 24.2. USA In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In-Vitro Lung Model Market

  • 25.1. Canada In-Vitro Lung Model Market Overview
  • 25.2. Canada In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In-Vitro Lung Model Market

  • 26.1. South America In-Vitro Lung Model Market Overview
  • 26.2. South America In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In-Vitro Lung Model Market

  • 27.1. Brazil In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In-Vitro Lung Model Market

  • 28.1. Middle East In-Vitro Lung Model Market Overview
  • 28.2. Middle East In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In-Vitro Lung Model Market

  • 29.1. Africa In-Vitro Lung Model Market Overview
  • 29.2. Africa In-Vitro Lung Model Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In-Vitro Lung Model Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In-Vitro Lung Model Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In-Vitro Lung Model Market Competitive Landscape And Company Profiles

  • 30.1. In-Vitro Lung Model Market Competitive Landscape
  • 30.2. In-Vitro Lung Model Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Lonza Group AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Charles River Laboratories International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. In-Vitro Lung Model Market Other Major And Innovative Companies

  • 31.1. Epithelix
  • 31.2. The Charles Stark Draper Laboratory Inc.
  • 31.3. STEMCELL Technologies
  • 31.4. American Type Culture Collection (ATCC)
  • 31.5. BioIVT
  • 31.6. InSphero
  • 31.7. Emulate Inc.
  • 31.8. PhoenixBio Co. Ltd.
  • 31.9. Newcells Biotech
  • 31.10. CN Bio Innovations Ltd.
  • 31.11. Mimetas
  • 31.12. Cyfuse Biomedical K.K.
  • 31.13. 3D Biotek LLC
  • 31.14. AlveoliX AG
  • 31.15. AxoSim Technologies LLC

32. Global In-Vitro Lung Model Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In-Vitro Lung Model Market

34. Recent Developments In The In-Vitro Lung Model Market

35. In-Vitro Lung Model Market High Potential Countries, Segments and Strategies

  • 35.1 In-Vitro Lung Model Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In-Vitro Lung Model Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In-Vitro Lung Model Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer